Quantitative analyses of spermatogenetic cell populations were undertaken in testes from three animals in each group. Spermatogonia designated as type A, intermediate and type B, spermatocytes at the first and second meiotic stages, spermatids, spermatozoa and Sertoli cells were examined for the number of cells after the treatment on the basis of 40 transverse sections of seminiferous tubules in each testis. For determining the changes in the number of germinal cells, tubules having the same diameter were studied. They were selected after determination of the proportion of each spermatogenetic cell population in 100 to 200 tubules occurring in each testis. The results were compared with those derived from the same number of tubules scored in the control mice and expressed as percentages against the control figures. Concerning the X-ray sensitivity of spermatogonia, type A, intermediate and type B spermatogonia were classified on the basis of the description of spermatid stages given by OAKBERG (1956) and counted in 100 tubule cross-sections for each of two mice. These results were also expressed as a percentage of the control values. At the same time, the diameters of 100 tubules were measured in each of two mice and the values were represented as percentages against the control values.
Results

Quantitative changes in spermatogenetic cells after the application of the drug
Data pertaining to the change in spermatogenetic cell populations induced after a single application of the drug at the dose level of 1.7 or 3.4mg/kg were summarized in Table 1 and shown by diagrams in Figures 1 and 2 .
Spermatogonia. After a single exposure to 1.7 or 3.4mg/kg, a rapid depletion of spermatogonia occurred within the 1st week giving the lowest values at 13.6 and 3.0% of the controls, respectively, whereas spermatogenetic cells of other types showed no remarkable decrease ( Fig. 1, 2) . A typical specimen taken from the 1st week after the administration of 3.4mg/kg showed the absence of spermatogonia with the existence of spermatocytes, spermatids and spermatozoa (Fig. 4) . The recovery of spermatogonia was observed in the tubules taken from the 2nd week in both cases. Their return to the control value in the 3.4mg/kg case, however, was approximately one week later than that of the 1.7mg/kg case and shown at the 4th week after the treatment (Fig. 1, 2) . Table 1 . Frequency of cell types at various times after treatment with Mitomycin-C* Spermatocytes. The disappearance of spermatocytes following the application of 3.4mg/kg occurred rapidly at the 2nd week showing the lowest value of 8.8%, the spermatocytes then gradually increased during the period from 3 to 6 weeks after the treatment (Fig. 7, 8) . Almost all the seminiferous tubules observed at the 2nd week were those containing only spermatids and spermatozoa (Fig. 5) . Following the injection of 1.7mg/kg, the spermatocytes decreased also at the same period giving the minimum value of 21.4% at the 2nd week, and then approached the control value at the 5th week (Fig. 1 Spermatids. No rapid decline in the number of spermatids occurred up to 2 weeks after the injection at 1.7 or 3.4mg/kg.
The number of spermatids observed at the 3rd week after the treatment, however, showed the minimum values of 24.4 and 6.6% of the controls, respectively. A typical aspect of the seminiferous tubules at the 3rd week after the injection of 3.4mg/kg was the occurrence of only spermatogonia and spermatozoa (Fig. 6) . From then on spermatids began to recover in the 4th week. The approach to the control value, however, was not observed in either of them throughout the period of this experiment (Fig. 1, 2) .
Spermatozoa. After a single injection at 1.7 or 3.4mg/kg, spermatozoa reduced rapidly to the minimum values of 28.0 and 4.9% at the 4th week, respectively.
Especially, spermatogenetic cells at this stage in the 3.4mg/kg case consisted of only spermatogonia and spermatocytes (Fig. 7) . Moreover, a remarkable diminution of these cells was observed at the 5th week, while in the 1.7mg/kg case they showed signs of recovery during the same period (Fig. 1) .
Sertoli cells. Sertoli cells were always present in the tubules treated at 1.7 or 3.4 mg/kg dose throughout this experiment showing values above the control ones. Further, severely disintegrated testes at the 3rd week exhibited a remarkable increase in the number of Sertoli cells (Table 1 and Fig. 3-8 ).
Comparative sensitivity of spermatogonia
The rates of decrease and recovery in the number of type A and type B spermatogonia were examined at weekly intervals after the administration of 1.7 or 3.4mg/kg and the data obtained are shown in Table 2 . Spermatogonia of intermediate type have been combined with those of type B in the preparation of the data. Type A spermatogonia. Table 2 shows that Mitomycin-C-injection resulted in a sharp decline in the number of type A spermatogonia at the 1st week after the treatment with the dosage of 3.4mg/kg.
By the 2nd week, repopulation was in progress (Fig. 11) and by the 3rd week, the number of type A cells had reached the control value. With the 1.7mg/kg dose, type A cells decreased at the 1st week to 25.3% of the control. The repopulation of those cells appeared to have been accelerated when compared with the 3.4mg/kg case.
Type B spermatogonia. Type B spermatogonia disappeared rapidly after the injection at 1.7 or 3.4mg/kg.
The number of apparently normal cells was found to reduce to 4.7 and 2.2%, respectively by the 1st week (Table 2 and Fig. 10 ). Later, in the 1.7 mg/kg case, type B cells repopulated the seminiferous tubules to the extent of 59.0% the 1st week after the injection, while spermatocytes from the 1st and the 2nd week specimens showed necrosis as well as abnormalities in the dividing cells. They were represented by stickiness, breaks and fragments of chromosomes at metaphase, and chromosomal bridges at anaphase. These facts seem to indicate that this agent causes damage to the chromosomes, leading to the failure of cell division. Furthermore, abnormalities of primary spermatocytes were also noted during a period ranging from the 4th to the 6th week which corresponds to the period of recovery of those cells.
Spermatids exhibited no visible decrease in number within 2 weeks after the treatment.
The seminiferous tubules at the 1st week, however, showed the presence of degenerating, sloughed spermatids ( Fig. 13 ). Further attention was directed toward the necrosis of those cells in the 2nd week specimens as well as to the variation in the size of nuclei during the period of their decrease and recovery in the 2nd and the 6th week specimens (Fig. 13, 14) . Sperm heads of unusual form were observed in a considerable number of the specimens 2 to 3 weeks after the injection (Fig. 15 ).
Other damages caused by the administration of this drug are represented by light green-positive precipitates and cytoplasmic "cast off" in the tubules: they were detected in the specimens obtained from the 1st to the 3rd week after exposure. Damage This change was especially conspicuous in the 3.4mg/kg specimens observed from the 2nd to the 4th week after the administration of the drug (Fig. 16 ). was seen in the specimens obtained 3 to 4 weeks after the administration (Fig. 30, 31 ). 5. Changes of the ductus epididymidis following the application of the drug Certain changes of caput and cauda epididymidis were examined in the specimens observed 1 to 6 weeks after the injection at 3.4mg/kg dosage. Saline-injected specimens showed the ductus epididymidis with a full complement of spermatozoa (Fig. 17, 18, 23, 24) .
In the caput epididymidis after the treatment spermatozoa decreased during the 4 weeks after exposure.
Complete absence of spermatozoa occurred at the 5th and the 6th week. In the ducts devoid of spermatozoa observed at the 4th and the 6th week, the occurrence of many sloughed spermatocytes and spermatids was remarkable (Fig.  19-22 ). On the other hand, the cauda epididymidis after exposure exhibited no apparent decrease in the number of spermatozoa, except in the 6th week specimens. Degenerating germ cells, however, showed a greater increase in the cauda than in the caput epididymidis with a gradual decrease of spermatozoa, so far as the scope of the present study is concerned. Those cells were represented by necrotic or degenerating spermatocytes.
Degenerating spermatids showed predominantly necrotic cells, variation in the size of the nuclei, abnormal spermioteleosis, signet-ring cells, and giant cells with two nuclei (Fig. 25-28 ). In addition, light green-positive precipitates and cytoplasmic "cast off" were also recognized in the duct.
6. Changes in testis-weight and tubule-diameter following the application of the drug
The change in weight of the testis was noted in the specimens after exposure at 1.7 or 3.4mg/kg dose; data obtained are as shown in Figure 29 . Testis-weight of the treated mice remained significantly less than that of controls in the materials observed in the present experiments.
A decrease in the testis-weight was less marked in the 1.7mg/kg specimens than in the 3.4mg/kg specimens.
Data shown in Figure 29 indicate that the group treated with 1.7mg/kg lost approximately 47% and 3.4mg/kg specimens 63% of the control testis-weight both showing the minimum value at the 4th week. An increase of the testis-weight was noted in both 1.7 and 3.4mg/kg specimens from the 5th week onward.
Data on change in the diameter of the seminiferous tubules in treated mice are shown in Figure 29 . It is evident from the data that tubule-diameter shows a gradual decrease from the 1st week, reaching the minimum at the 4th week with an increase after the 5th week in both cases. Furthermore, the tubule-diameter in the 4th week specimens showing the lowest value had lost 26% and 32% of the control diameter in the 1.7 and 3.4mg/kg cases, respectively (Fig. 31) . The rate of decrease in the tubule-diameter was less marked in comparison with that of the testis-weight over the same period. of X-rays (ITAGAKI, 1962 (ITAGAKI, , 1966 ITO and ITAGAKI, 1963 MAKINO and his co-workers (1956 to 1964) . They reported that the pattern of damage of tumor cells is specific to each agent; Sarkomycin exerted a specific action on the cytoplasm and the nucleolus of the resting cells, while the destructive action of Carzinophilin was much more severe to the nucleus than to the cytoplasm; in the dividing cells, chromosome stickiness and coalescence were evident with the former, while chromosome breakage and bridge-formation were common with the latter (HORI and SASAKI, 1958) .
It has been shown by HATA et al. (1956) that Mitomycin-C affects certain rat and mouse tumors with a strong antagonistic action. Furthermore, SUGIURA (1959) reported that Mitomycin-C was the most effective among 22 crystalline or purified antibiotics tested, and that the drug had a destructive effect on certain carcinomas and sarcomas of rats, mice and hamsters.
Working on cytological and cytochemical observations on the effects of Mitomycin-C upon cells of the MTK-sarcoma III of rats and EMtumor of mice, KOBAYASHI (1960) described that the effect of Mitomycin-C was to damage the DNA in the resting nucleus, and that a change in the nature of RNA in the nucleolus occurred in association with the damage to the DNA. In the experiments with Escherichia coli, SHIBA et al. (1958), and SEKIGUCHI and TAKAGI (1960) concluded that the effect of Mitomycin-C was to inhibit DNA synthesis specifically. In the study with the virus, REICH and FRANKLIN (1961) have reached the same conclusion that this agent induced the inhibition of DNA synthesis without affecting RNA synthesis.
In addition, KOBAYASHI (1960) reported that mitotic cells following the application of Mitomycin-C showed irregular elongation, translocation and fragmentation of the chromosomes at pro-and metaphase, and the formation of chromosome bridges at anaphase and telophase. KIMURA (1963) , working with HeLa cells in vitro, presented evidence that Mitomycin-C induced a severe pycnosis in resting cells together with lobated nuclei and blebbing or vacuolization of the cytoplasm.
The present experiments have revealed the suppression of cell division and necrosis of the resting as well as dividing cells, the chromosome-breakage and sticky chromosomes at metaphase and the bridge formation at anaphase in spermatogonia and predominantly in spermatocytes in response to the application of Mitomycin-C. The process of spermatogonial depletion during the 1st week after the treatment was not grasped in detail since the present study was made at weekly intervals. Evidence was presented, however, to indicate that treated spermatogonia begin to degenerate showing the necrosis and chromosomal aberrations in dividing cells immediately after exposure, and that their degeneration gives rise to the depletion of spermatogonia themselves.
This suggestion seems to be supported further on the basis of the finding that spermatogonia disappeared remarkably within 48 hours after the X-ray irradiation showing the necrosis of cells in mouse testes (OAKBERG, 1955; ITAGAKI, 1967) . Furthermore, based on the occurrence of the necrotic as well as abnormal mitotic figures of primary spermatocytes at the 1st week after exposure, it renders possible the suggestion that the damaging action of Mitomycin-C to primary spermatocytes in the resting and prophase stages remains latent until the cells enter meiotic division and chromosomal aberrations then occur, or that the drug induces the death of these cells immediately after treatment.
The fact that a remarkable decrease of spermatids and spermatozoa was not observed within 2 or 3 weeks after the drug application implies that these cells have a high resistance to the agent. The presence of degenerating sloughed spermatids at the 1st week, and the variation in size of these cell nuclei and abnormal sperm heads at the 2nd week seem to be attributable to exposed spermatogonia, derived from spermatocytes for the most part, as described in the earlier paper (ITAGAKI, 1966) . It seems also apparent that the depletion of spermatids and spermatozoa following the application is ascribed to the obstruction of spermatogenesis induced by the disappearance of spermatogonia.
Furthermore, the data derived from the present experiments indicate that both initial depletion and subsequent regeneration of spermatogenetic cells depend on the response of spermatogonia to the drug, and that the sensitivity to Mitomycin-C differs between type A and type B spermatogonia. Table 2 regarding the effects of Mitomycin-C on spermatogonia shows taht type B cells are more sensitive than type A cells. Moreover, the existence of type A cells in damaged tubules seems to suggest a possibility that dormant type A cells survive after the drug application and repopulate new spermatogenetic elements. In the application of several antibiotics to tumor cells, it has been observed cytologically that some of the stem line cells remain alive maintaining their individuality and constitute renewed neoplastic growth through to inquire into the characteristic nature of surviving cells following their exposure to chemicals and X-rays in order to obtain criteria useful for understanding the mechanism of regrowth and regression of tumor cells.
With respect to the difference in Mitomycin-sensitivity between type A and type B spermatogonia, the results derived from X-rays as well as Mitomycin-C experiments may be in favor of the view of MONESI (1962) . He reported in the study of the difference in sensitivity between type A and type B spermatogonia in mouse testes using tritiated thymidine that the much longer duration of the X-ray-sensitive period (interphase) and the much shorter duration of the X-ray-resistant period (prophase) of the cell cycle in intermediate and type B spermatogonia in comparison with type A spermatogonia may possibly account for the greater X-ray-sensitivity of intermediate and type B cells. Further, he noted that the depression of the incorporation of precursors into DNA after irradiation would be merely the consequence of the inhibition of the onset of DNA synthesis (G1 block) or of the mitotic delay, resulting from the G2 block, or both, rather than the result of a depression of DNA synthesis itself. TAJIMA and ONIMARU (1966) , in the study of mutation induction by Mitomycin-C in the silkworm, reported that the drug seems to act on the cells of G1 or G2 stage, or on the elongation of the depression of DNA synthesis. Recently DJORDJEVIC and KIM (1968) , in studying the lethal actions of Mitomycin-C during the division cycle of HeLa cells, observed that the toxicity of Mitomycin-C is greatest during the early phases (G1) of the cycle. SATO (1967) also, in an autoradiographic study using the root meristem of Vicia faba, described that Mitomycin-C causes considerable damage to each stage of interphase. From the histological and cytochemical standpoints it is suggested that the action of Mitomycin-C and X-rays on germ cells may be of similar character.
combined application of an antibiotic and some other drug, such as Sarkomycin-Podophylotoxin, and Mitomycin-C-Carzinophilin, exerts a more deleterious effect upon tumor cells than by their individual application. MATSUURA et al. (1962 MATSUURA et al. ( , 1963 , in the study of the effect of Mitomycin-C on the frequency of X-ray-induced chromosome aberrations in ovular tissue cells of Trillium kamtschaticum, stated that Mitomycin-C is effective in increasing the chromosome aberrations at metaphase after irradiation. In the field of medical treatment of tumor patients it is to be expected that a combined therapy of Mitomycin-C and X-rays induces a remarkable damage upon tumor cells. The author has attempted to compare the results of the present experiment with those of studies with X-rays (ITAGAKI, 1962 (ITAGAKI, , 1966 ITO and ITAGAKI 1963) especially with regard to the rate of the decrease and recovery of spermatogonia showing the highest sensitivity with a desire to obtain critical information on the relative relation between dosages of Mitomycin-C and X-rays. It is shown in Figure 32 that the minimum value of spermatogonia after Mitomycin-treatment at 1.7 or 3.4mg/kg dose was obtained at the 1st week in both experimental specimens, and that their approach to the control levels was approximately at the 3rd and the 4th week, respectively, after the treatment.
On the other hand, the depletion of spermatogonia irradiated with 100, 300, and 500r of X-rays also occurred at the 1st week in all cases and their return to the control was observed at the 2nd, 3rd and 4th week after irradiation. Evidence presented here strongly suggests that the dose of 1.7mg/kg of Mitomycin-C corresponds well to the dose of 300r of X-rays, and further that the 3.4mg/kg dosage of Mitomycin-C is comparable to the dose of 500r of X-rays.
Sertoli cells increased in damaged tubules suggesting their resistance to the agent. NEBEL and MURPHY (1960) reported that no dividing feature of Sertoli cells was observed in radioautographic study undertaken with tritiated thymidine. From the fact that Sertoli cells increase after the drug application and return to the control value with the recovery of spermatogenetic cell populations, it seems probable that the increase of Sertoli cells is related to the shrinkage of seminiferous tubules as a result of the disappearance of affected cells. The testis-weight of exposed mice began to decrease gradually at the 1st week and reached the lowest value between the 3rd and the 4th week after the treatment. Histological observations of these testes also showed a remarkable decrease of spermatogenetic cells in the same period after the drug application.
In the light of the results obtained from the present experiments, the suggestion is possible that the decrease of the testis-weight is correlated with the decrease in number of germ cells after the treatment. Further, from the fact that the tubule-diameter showed a remarkable shrinkage during the 1st week to the 4th week after exposure, the data at hand indicate that there is a close relation between the shrinkage of seminiferous tubules and the damage of spermatogenetic cells following the application of the drug.
The rate in decrease of the testis-weight is more marked than that of the tubulediameter. On this basis it appears that the testis-weight curve is useful as a practical value in setting up experiments for comparative chemotherapy.
Summary
The damage to spermatogenetic cells of mice following the application of Mitomycin-C (1.7 or 3.4mg/kg) was studied on some quantitative and histological bases with particular attention to the sensitivity of spermatogenetic cells of each population, and the results obtained were compared with those from X-ray-irradiated mice. A remarkable decrease of spermatogonia, spermatocytes, spermatids and spermatozoa occurs in the order of their developmental stages at the 1st, 2nd, 3rd and 4th week after the treatment.
Evidence presented implies that the sensitivity of spermatogenetic cells to the drug differs by their developmental stages.
The decrease of these cell types was more marked with the increased concentration of the drug. Their return to the control value in the 3.4mg/kg case is one week later than that in the 1.7mg/kg case.
It has been shown that spermatogonia are more sensitive than germ cells of other types, and that type B spermatogonia are higher in sensitivity than type A spermatogonia.
Spermatocytes show necrosis at the resting stage as well as in the process of division and chromosome aberrations at metaphase and anaphase.
Evidence is available to show that some spermatocytes seem to participate in the formation of abnormal spermatids and spermatozoa, or otherwise, slough in the ductus epididymidis.
No pathological changes were observed to occur in spermatids and spermatozoa treated with the drug. Their depletion seems to be attributable to the obstruction of spermatogenesis due to the disappearance of spermatogonia. Sertoli cells and interstitial cells show a gradual increase following the application of the drug suggesting a correlation with the shrinkage of seminiferous tubules.
The rate in decrease of the testis-weight after the treatment with the drug is more marked than that of the tubule-diameter.
Further, the features involving decrease and recovery of the testis-weight and the tubule-diameter can be explained on the basis of the destruction and recovery of spermatogenetic cells.
Data so far presented make it possible to conclude that Mitomycin-C and X-rays seem to affect male germ cells leading to their ultimate damage in a generally similar manner.
The relative dosage between Mitomycin-C and X-rays considered on the basis of disappearance and recovery rate of spermatogonia seems to be as follows:
1.7mg/kg of Mitomycin-C corresponds approximately to the dose of 300r of X-rays and 3.4mg/kg to the dose of 500r.
